Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden.
(2016) In Journal of Rheumatology 43(1). p.81-87- Abstract
- Because new modes of action for the treatment of psoriatic arthritis (PsA) are emerging, it is important to understand the use of switching to a second or third antitumor necrosis factor (anti-TNF) agent. This study investigated drug survival and treatment response rates of patients with PsA undergoing second- and third-line anti-TNF therapy.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8505839
- author
- Kristensen, Lars Erik LU ; Lie, Elisabeth ; Jacobsson, Lennart ; Christensen, Robin ; Mease, Philip J ; Bliddal, Henning and Geborek, Pierre LU
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Rheumatology
- volume
- 43
- issue
- 1
- pages
- 81 - 87
- publisher
- Journal of Rheumatology Publishing Company Limited
- external identifiers
-
- pmid:26628604
- wos:000367459200013
- pmid:26628604
- scopus:85011898441
- ISSN
- 0315-162X
- DOI
- 10.3899/jrheum.150744
- language
- English
- LU publication?
- no
- id
- 6b9b5b96-2b30-4339-9f1e-3c2c34ce8fd7 (old id 8505839)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26628604?dopt=Abstract
- date added to LUP
- 2016-04-01 09:55:05
- date last changed
- 2022-03-27 03:04:24
@article{6b9b5b96-2b30-4339-9f1e-3c2c34ce8fd7, abstract = {{Because new modes of action for the treatment of psoriatic arthritis (PsA) are emerging, it is important to understand the use of switching to a second or third antitumor necrosis factor (anti-TNF) agent. This study investigated drug survival and treatment response rates of patients with PsA undergoing second- and third-line anti-TNF therapy.}}, author = {{Kristensen, Lars Erik and Lie, Elisabeth and Jacobsson, Lennart and Christensen, Robin and Mease, Philip J and Bliddal, Henning and Geborek, Pierre}}, issn = {{0315-162X}}, language = {{eng}}, number = {{1}}, pages = {{81--87}}, publisher = {{Journal of Rheumatology Publishing Company Limited}}, series = {{Journal of Rheumatology}}, title = {{Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden.}}, url = {{http://dx.doi.org/10.3899/jrheum.150744}}, doi = {{10.3899/jrheum.150744}}, volume = {{43}}, year = {{2016}}, }